IMNM
Immunome, Inc.
Stock
$20.90+0.01 (+0.05%)Close Oct 2, 2026
- Capital expenditures, 2025
- $9.7M
- YoY, 2025
- +35.0%
- 5-year CAGR
- +75.2%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $9.7M | +35.0% |
| 2024 | $7.2M | +763.2% |
| 2023 | $831K | +235.1% |
| 2022 | $248K | +213.9% |
| 2021 | $79K | −86.5% |
| 2020 | $586K | +151.5% |
| 2019 | $233K | — |